-
iShares U.S. Healthcare ETF (IYH $65.86)
- $65.86 P/E (TTM): 23.71X Cap: $3.53B
- View IYH Profile
- View Questions on IYH
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $488.15)
- $488.15 P/E (TTM): 63.21X Cap: $169.15B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 165.73X Cap: $387.09B
- View ABBV Profile
- View Questions on ABBV
-
Stryker Corporation (SYK $358.29)
- $358.29 P/E (TTM): 47.39X Cap: $138.59B
- View SYK Profile
- View Questions on SYK
-
Veeva Systems Inc. Class A (VEEV $183.65)
- $183.65 P/E (TTM): 37.17X Cap: $30.22B
- View VEEV Profile
- View Questions on VEEV
-
iShares U.S. Healthcare ETF (IYH $65.86)
- $65.86 P/E (TTM): 23.71X Cap: $3.53B
- View IYH Profile
- View Questions on IYH
-
TransMedics Group Inc. (TMDX $135.06)
- $135.06 P/E (TTM): 52.57X Cap: $4.61B
- View TMDX Profile
- View Questions on TMDX
Q: I have owned this for a few years now. I had to be patient but you seemed to hold it in favour throughout.
I thought my patience was rewarded with good growth in 2025, but over the past few months, it has lost all that growth.
Can you explain what has been going on?
I'm also low in healthcare in my portfolio. This seems like a good time to redress that. What would be your top three buys for a long term holding? Do you generally prefer companies or ETFs for this sector?
Thanks for all the great work you provide. I was happy to renew recently.
I thought my patience was rewarded with good growth in 2025, but over the past few months, it has lost all that growth.
Can you explain what has been going on?
I'm also low in healthcare in my portfolio. This seems like a good time to redress that. What would be your top three buys for a long term holding? Do you generally prefer companies or ETFs for this sector?
Thanks for all the great work you provide. I was happy to renew recently.
-
iShares U.S. Healthcare ETF (IYH $65.86)
- $65.86 P/E (TTM): 23.71X Cap: $3.53B
- View IYH Profile
- View Questions on IYH
Q: Healthcare hasn’t done very much but I don’t have any in my portfolio. What etf would you recommend . Greetings Peter.
-
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 165.73X Cap: $387.09B
- View ABBV Profile
- View Questions on ABBV
-
iShares U.S. Healthcare ETF (IYH $65.86)
- $65.86 P/E (TTM): 23.71X Cap: $3.53B
- View IYH Profile
- View Questions on IYH
Q: We have held ABBV for the past five years in our two RRIF accounts. It is now a 4.1% position with a 120% gain. Is it time to take profits and move on, given that the dividend is now at a yield just around 3%. Are there better health care dividend growth positions? ETF's or single stocks. It is a solid company. Is it best to just keep holding.
Insiders
Share Information
SEC Filings
News and Media